Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cancer Research|March 1, 1986
Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liverH Ochs, B Düsterberg, P Günzel, et al.
Contraception|June 1, 1995
The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodeneN Fuchs, B Düsterberg, F Weber-Diehl, et al.
Contraception|February 1, 1996
A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiolU H Winkler, A E Schindler, J Endrikat, et al.
Contraception|March 16, 2000
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical studyJ Endrikat, B Düsterberg, A Ruebig, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 1, 1996
A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodeneB Düsterberg, H Ellman, U Müller, et al.
Teratology|April 1, 1984
Norethisterone acetate and ethinylestradiol in early human pregnancyM O Pulkkinen, B Düsterberg, H Hasan, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|January 5, 2002
Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 g gestodeneJ Endrikat, C Gerlinger, M Cronin, et al.
Contraception|November 13, 2001
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrelJ Endrikat, M Cronin, C Gerlinger, et al.
Contraception|November 13, 2001
Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 microg ethinyl estradiol and 75 microg gestodeneJ Endrikat, M Cronin, C Gerlinger, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1995
Hormonal oral contraceptives, urinary porphyrin excretion and porphyriasU Gross, M Honcamp, E Daume, et al.
Pageof 4